621 reports of this reaction
3.2% of all PARICALCITOL reports
#2 most reported adverse reaction
CARDIAC DISORDER is the #2 most commonly reported adverse reaction for PARICALCITOL, manufactured by AbbVie Inc.. There are 621 FDA adverse event reports linking PARICALCITOL to CARDIAC DISORDER. This represents approximately 3.2% of all 19,271 adverse event reports for this drug.
Patients taking PARICALCITOL who experience cardiac disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIAC DISORDER is moderately reported among PARICALCITOL users, representing a notable but not dominant share of adverse events.
In addition to cardiac disorder, the following adverse reactions have been reported for PARICALCITOL:
The following drugs have also been linked to cardiac disorder in FDA adverse event reports:
CARDIAC DISORDER has been reported as an adverse event in 621 FDA reports for PARICALCITOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIAC DISORDER accounts for approximately 3.2% of all adverse event reports for PARICALCITOL, making it one of the most commonly reported side effect.
If you experience cardiac disorder while taking PARICALCITOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.